Digital biomanufacturing and AI at Cell 2026
Nov 12–13, 2026 London, UK ~800 attendees Website
12 organizations at Cell 2026 present work in digital biomanufacturing and AI: 6 drug developers and 6 suppliers and service providers. Between them they bring 23 presentations to the program. Most represented: AstraZeneca (4 on the program), Resolution Therapeutics (4 on the program), TreeFrog Therapeutics (2 on the program). 9 of them have their own page in this guide. As of Oct 8, 2026.
Format
Top represented
Showing 1–12 of 12 organizations
| Organization | Cell 2026 Attendance |
|---|---|
AstraZeneca Cambridge, UK | |
Global drugmaker with medicines in oncology, cardiovascular, respiratory, immunology and rare disease, and a cell therapy pipeline. | Panel Thu Nov 12 12:25pm–12:50pm Cracking In Vivo Delivery For Next-Generation Gene Therapies Cell and gene therapy Panel Thu Nov 12 12:25pm–12:50pm The Productivity Challenge: How Can The Industry Deliver More Medicines With Less Manufacturing and CMC Panel Thu Nov 12 2:40pm–3:05pm Where Does Big Pharma Stand In CGTs – And What Comes Next? Cell and gene therapy Talk Thu Nov 12 3:05pm–3:30pm Mapping Immune Vulnerabilities: CRISPR Screens for Target Discovery Stem cells, organoids and cell models Talk Fri Nov 13 3:10pm–3:35pm Cell Line Database Development Cell line developmentDigital biomanufacturing and AI Talk Fri Nov 13 3:50pm–4:15pm Clinical Trial Designs For Advanced Therapies Outside Of Oncology Cell and gene therapy Talk Fri Nov 13 4:15pm–4:40pm Reduction Of Animal Bi-Products In Cell Cultures Cell culture and upstream processing |
Resolution Therapeutics London, UK | |
Develops regenerative macrophage therapies for inflammatory and fibrotic diseases, led by a programme in end-stage liver disease. | Talk Thu Nov 12 10:15am–10:40am Building For The Future: Phase-Appropriate CMC Strategies Manufacturing and CMC Panel Thu Nov 12 2:40pm–3:05pm The AI Reality Check: What’s Ready Now, What Isn’t, And How Do We Validate It Safely? Digital biomanufacturing and AI Panel Fri Nov 13 4:40pm–5:05pm Panel Fri Nov 13 4:40pm–5:05pm Navigating The Regulatory Lifecycle Of Advanced Therapies: From Platform Approval To Manufacturing & Post-Market Evidence Cell and gene therapyManufacturing and CMC Talk Fri Nov 13 5:05pm–5:30pm |
TreeFrog Therapeutics Bordeaux, France | |
Develops cell therapies from pluripotent stem cells grown in its C-Stem 3D encapsulation platform, with a lead program in Parkinson's disease. | Panel Thu Nov 12 2:40pm–3:05pm The AI Reality Check: What’s Ready Now, What Isn’t, And How Do We Validate It Safely? Digital biomanufacturing and AI Panel Fri Nov 13 9:25am–9:50am Talk Fri Nov 13 11:40am–12:05pm Bridging Development and Manufacturing Through Predictive Scaling Manufacturing and CMCCell culture and upstream processing Talk Fri Nov 13 2:45pm–3:10pm Cell Therapy: From Therapeutic Potential To Sustainable Patient Access Cell and gene therapy |
Hogan Lovells London, UK | |
International law firm advising life sciences companies on regulatory, intellectual property and transactional matters. | Panel Thu Nov 12 2:40pm–3:05pm The AI Reality Check: What’s Ready Now, What Isn’t, And How Do We Validate It Safely? Digital biomanufacturing and AI Talk Fri Nov 13 12:05pm–12:30pm Changing Regulatory Environment For CGTs In 2027 (SoHO Regulations) Cell and gene therapy Talk Fri Nov 13 3:10pm–3:35pm Featured Session: AI In Decision-Making - EU's AI Perspective Digital biomanufacturing and AI |
Lir Therapeutics London, UK | |
Engineers viral vectors with machine learning to make gene therapy delivery more efficient, precise and lower-dose. | Talk Thu Nov 12 9:25am–9:50am Accelerating Viral Gene Therapy Delivery With AI Cell and gene therapyDigital biomanufacturing and AI |
Sanofi Paris, France | |
Global drugmaker with vaccines and medicines for immunology, rare diseases, neurology and oncology. | Talk Thu Nov 12 10:15am–10:40am Digital Twin Modelling For Accelerating Technical Transfer For Upstream Processes & As Digital Shadows In Commercial Manufacturing Digital biomanufacturing and AICell culture and upstream processing |
Servier Symphogen Ballerup, Denmark | |
Servier's antibody research centre in Denmark, developing antibody therapies for cancer. | Talk Thu Nov 12 5:20pm–5:45pm Use Of Temporal Profile Predictions In Cell Culture Cell culture and upstream processingDigital biomanufacturing and AI |
Sapio Sciences Baltimore, Maryland | ◇Bronze Sponsor |
Makes lab informatics software, including LIMS and electronic lab notebook platforms, for research and bioprocess labs. | Talk Thu Nov 12 3:30pm–3:55pm |
In the Start-Up Zone | |
Applied AI lab building agent systems and models that help pharma and biotech R&D teams analyse multi-modal data. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
○Network & Programme Sponsor | |
Makes modular robots that automate cell culture, cryogenic sample storage and vial handling, with scheduling and traceability software. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
○Network & Programme Sponsor | |
Software that connects bioreactor, instrument, LIMS and CDMO data for cell and gene therapy process teams, with audited AI analysis. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
In the Start-Up Zone | |
Makes AI software that recommends bioreactor settings, scale-up and purification conditions to raise product yield with fewer experiments. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Instantly find 20 buyers in digital biomanufacturing and AI
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse Cell 2026 by
Organization type
Topic
Everyone
Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction